Suchergebnisse - "Barlesi, F"

PubPharm (9)

1

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Peyraud, F. | Guégan, J. | Bodet, D. | +20

2

Radiotherapy for oligometastatic non-small cell lung cancer patients

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2021

von Levy, A. | Roux, C. | Mercier, O. | +4

3

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure : a case report

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Michot, J. | Albiges, L. | Chaput, N. | +12

4

Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer : updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Barlesi, F. | Scherpereel, A. | Gorbunova, V. | +14

5

Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab : a consensus report from a panel of experts

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Reck, M. | Barlesi, F. | Crinò, L. | +4

6

Anti-angiogenic factors in thoracic oncology : successes, failures and prospects

enthalten in: Revue des maladies respiratoires | 2011

von Marco, S. | Tomasini, P. | Greillier, L. | +1

7

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Barlési, F. | Balleyguier, C. | Besse, B. | +13

8

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trial

enthalten in: Lancet (London, England) | 2009

von Pirker, R. | Pereira, J. | Szczesna, A. | +116

CommentIn: Lancet. 2009 May 2;373(9674):1497-8. - PMID 19410696

9

Targeted therapies. New hopes, new challenges

enthalten in: Revue des maladies respiratoires | 2008

von Barlési, F.

1
[1]